1998
DOI: 10.1073/pnas.95.7.3408
|View full text |Cite
|
Sign up to set email alerts
|

Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme

Abstract: Tumor necrosis factor-␣ (TNF␣) is a cytokine that induces protective inf lammatory reactions and kills tumor cells but also causes severe damage when produced in excess, as in rheumatoid arthritis and septic shock. Soluble TNF␣ is released from its membrane-bound precursor by a membrane-anchored proteinase, recently identified as a multidomain metalloproteinase called TNF␣-converting enzyme or TACE. We have cocrystallized the catalytic domain of TACE with a hydroxamic acid inhibitor and have solved its 2.0 Å c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
259
0
4

Year Published

2000
2000
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 371 publications
(274 citation statements)
references
References 28 publications
8
259
0
4
Order By: Relevance
“…One possible explanation for the lack of processing of KL2SSTL/KAAK is that ADAM17 has an extended recognition sequence in Kitl2 for processing that includes these two sequences, but requires only one to be present. This notion is consistent with the crystal structure of ADAM17, which shows an extended peptidebinding groove in the catalytic site (Maskos et al, 1998). Finally, it is possible that ADAM17 uses binding sites in the ectodomain of Kitl as a determinant for its recognition, and then proceeds to cleave the substrate in a membrane proximal position without a strong cleavage site preference, but nevertheless requires either SSTL141-144 or KAAK150-153 to be present in Kitl2.…”
Section: Discussionsupporting
confidence: 82%
“…One possible explanation for the lack of processing of KL2SSTL/KAAK is that ADAM17 has an extended recognition sequence in Kitl2 for processing that includes these two sequences, but requires only one to be present. This notion is consistent with the crystal structure of ADAM17, which shows an extended peptidebinding groove in the catalytic site (Maskos et al, 1998). Finally, it is possible that ADAM17 uses binding sites in the ectodomain of Kitl as a determinant for its recognition, and then proceeds to cleave the substrate in a membrane proximal position without a strong cleavage site preference, but nevertheless requires either SSTL141-144 or KAAK150-153 to be present in Kitl2.…”
Section: Discussionsupporting
confidence: 82%
“…Total RNA from Karpas 299 cells was extracted with Trizol reagent (Life Technologies, Karlsruhe, Germany), digested with RNase-free DNase I (Roche Diagnostics, Mannheim, Germany), and cDNA synthesis was performed using a SuperScript Preamplification System and oligo(dT) [12][13][14][15][16][17][18] primers (Life Technologies). For an amplification of the cDNA fragment encoding the catalytic, disintegrin, and cysteine-rich domain of TACE, total cDNA was subjected to 30 cycles of PCR using proofreading polymerase (Elongase Enzyme mix; Life Technologies).…”
Section: Cloning Of the Human Tace Ectodomain And Its Expression As Gmentioning
confidence: 99%
“…Metalloproteinase-disintegrins belong to the metzincin superfamily of metalloproteinases encompassing the physiologically important families of MMPs, reprolysins and astacins. Due to their x-ray crystal structure, metalloproteinase-disintegrins are closely related to snake venom metalloproteinases (reprolysins) and are therefore regarded as members of the reprolysin family of metalloproteinases (13). Both snake venom proteinases and metalloproteinase-disintegrins exhibit membrane protein sheddase activity through their catalytic domain (11,12,14) and binding to cellular disintegrin receptors mediated by the disintegrin domain (15)(16)(17).…”
mentioning
confidence: 99%
“…Another interesting structural difference of TACE is that S1' and S3' subsites, separated on the surface by the side chains of residues Ala439 and Leu348, are merged below the surface. 25 This feature will be discussed in more detail in section Specificity Determinants and Comparison with Inhibitor Data.…”
Section: Structures and Superpositionmentioning
confidence: 99%